福森药业(01652)：归属安排已生效，曹智铭于公司的投票权增加至约45.29%

智通财经2025-05-26

智通财经APP讯，福森药业(01652)发布公告，本公司获曹智铭先生(前称曹笃笃先生)告知，归属安排已于2025年5月23日生效，而根据授产安排契据及投资管理协议已免除曹先生为福森信托的投资管理人的职务。因此，曹智铭先生已获授予投资及管理职能以及指示福森信托受托人据此投票的权力，曹智铭先生届时有权对福森信托股份附带的投票权行使控制及指示权。曹智铭先生于本公司的投票权因归属安排已由1.55亿股股份(...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2538310805?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-26 19:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2538310805","market":"us","top_or_hot":-1,"title":"福森药业(01652)：归属安排已生效，曹智铭于公司的投票权增加至约45.29%","media":"智通财经","content":"<div>\n<p>智通财经APP讯，福森药业(01652)发布公告，本公司获曹智铭先生(前称曹笃笃先生)告知，归属安排已于2025年5月23日生效，而根据授产安排契据及投资管理协议已免除曹先生为福森信托的投资管理人的职务。因此，曹智铭先生已获授予投资及管理职能以及指示福森信托受托人据此投票的权力，曹智铭先生届时有权对福森信托股份附带的投票权行使控制及指示权。曹智铭先生于本公司的投票权因归属安排已由1.55亿股股份(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1297680.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>福森药业(01652)：归属安排已生效，曹智铭于公司的投票权增加至约45.29%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n福森药业(01652)：归属安排已生效，曹智铭于公司的投票权增加至约45.29%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-26 19:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1297680.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，福森药业(01652)发布公告，本公司获曹智铭先生(前称曹笃笃先生)告知，归属安排已于2025年5月23日生效，而根据授产安排契据及投资管理协议已免除曹先生为福森信托的投资管理人的职务。因此，曹智铭先生已获授予投资及管理职能以及指示福森信托受托人据此投票的权力，曹智铭先生届时有权对福森信托股份附带的投票权行使控制及指示权。曹智铭先生于本公司的投票权因归属安排已由1.55亿股股份(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1297680.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01652","symbol_name":"福森药业","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1297680.html","article_id":"2538310805","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2538310805","pubTimestamp":1748258274,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，福森药业(01652)发布公告，本公司获曹智铭先生(前称曹笃笃先生)告知，归属安排已于2025年5月23日生效，而根据授产安排契据及投资管理协议已免除曹先生为福森信托的投资管理人的职务。因此，曹智铭先生已获授予投资及管理职能以及指示福森信托受托人据此投票的权力，曹智铭先生届时有权对福森信托股份附带的投票权行使控制及指示权。曹智铭先生于本公司的投票权因归属安排已由1.55亿股股份(占已发行股份总数约20.92%)增加至3.35亿股股份(占已发行股份总数约45.29%)。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01652":"福森药业","BK1191":"制药"},"translate_title":"Fusen Pharmaceutical (01652): The vesting arrangement has taken effect, and Cao Zhiming's voting rights in the company have increased to about 45.29%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01652":1},"content_text":"智通财经APP讯，福森药业(01652)发布公告，本公司获曹智铭先生(前称曹笃笃先生)告知，归属安排已于2025年5月23日生效，而根据授产安排契据及投资管理协议已免除曹先生为福森信托的投资管理人的职务。因此，曹智铭先生已获授予投资及管理职能以及指示福森信托受托人据此投票的权力，曹智铭先生届时有权对福森信托股份附带的投票权行使控制及指示权。曹智铭先生于本公司的投票权因归属安排已由1.55亿股股份(占已发行股份总数约20.92%)增加至3.35亿股股份(占已发行股份总数约45.29%)。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2538310805","isCrawlerRequest":true}